Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Avadel Pharmaceuticals plc shares valued at $39,640 were purchased by Palczuk Linda on Jan 21 ’25. At $7.93 per share, Palczuk Linda acquired 5,000 shares. The insider’s holdings grew to 67,900 shares worth approximately $0.64 million following the completion of this transaction.
Also, Thornton Peter J. purchased 10,000 shares, netting a total of over 80,450 in proceeds. Following the buying of shares at $8.04 each, the insider now holds 104,055 shares.
Before that, Ende Eric J had added 30,000 shares to its account. In a trade valued at $235,218, the Director bought Avadel Pharmaceuticals plc shares for $7.84 each. Upon closing the transaction, the insider’s holdings increased to 30,000 shares, worth approximately $1.97 million.
As published in their initiating research note from Deutsche Bank on February 11, 2025, Avadel Pharmaceuticals plc [AVDL] has been a Buy and the price target has been revised to $12. Analysts at Rodman & Renshaw started covering the stock with ‘”a Buy”‘ outlook in a report released in mid June. As of March 05, 2024, Oppenheimer has reiterated its “an Outperform” rating for AVDL. Earlier on March 05, 2024, Needham resumed its rating. Their recommendation was “a Buy” for AVDL stock.
Analyzing AVDL Stock Performance
On last trading session,, Avadel Pharmaceuticals plc [NASDAQ: AVDL] plunged -1.67% to $9.44. The stock’s lowest price that day was $9.3101, but it reached a high of $9.605 in the same session. During the last five days, there has been a surge of approximately 0.75%. Over the course of the year, Avadel Pharmaceuticals plc shares have dropped approximately -37.11%. Shares of the company reached a 52-week high of $11.52 on 01/03/25 and a 52-week low of $6.38 on 04/09/25.
Support And Resistance Levels for Avadel Pharmaceuticals plc (AVDL)
According to the 24-hour chart, there is a support level at 9.30, which, if violated, would cause prices to drop to 9.16. In the upper region, resistance lies at 9.59. The next price resistance is at 9.75. RSI (Relative Strength Index) is 51.70 on the 14-day chart, showing neutral technical sentiment.
Is Avadel Pharmaceuticals plc subject to short interest?
Stocks of Avadel Pharmaceuticals plc saw a sharp rise in short interest on 2025-05-30 jumping by 1.15 million shares to 11.33 million. Data from Yahoo Finance shows that the short interest on 2025-04-30 was 10.18 million shares. A jump of 10.19% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 8.77 of the overall float, the days-to-cover ratio (short ratio) jumped to 8.77.
Which companies own the most shares of Avadel Pharmaceuticals plc (AVDL)?
In terms of Avadel Pharmaceuticals plc share price expectations, FactSet research, analysts set an average price target of 20 in the next 12 months, up nearly 108.33% from the previous closing price of $9.6. Analysts anticipate Avadel Pharmaceuticals plc stock to reach 21 by 2025, with the lowest price target being 19. In spite of this, 8 analysts ranked Avadel Pharmaceuticals plc stock as Buy at the end of 2025. On March 05, 2024, H.C. Wainwright assigned a price target of “a Buy” to the stock and reiterated coverage with a $25.
